Kate O'Connell (Dublin Bay South, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Professor Finn is a pharmacologist. Is it true to say that the lack of clear pharmacological pathways for the action of cannabis could be holding it back? Normally, a standard drug interacts with a receptor and elicits an effect. Where we have something for which we cannot define the pathway, we could have potentially unintended side effects. I am putting the question to Professor Finn as a pharmacologist. We could have unintended or unforeseen interactions with other molecules because the tests have not been done. I am assuming Professor Finn would accept that as a pharmacologist.